This Is Precision in Practice

The iRhythm® service featuring Zio® ECG monitors – say hello to a comprehensive approach to cardiac monitoring.

Easy-to-wear monitors.1 Outstanding patient compliance.2 Exceptional accuracy.3 With our end-to-end service, we've completely changed the world of cardiac monitoring.4-7

Female physician

Learn how our end-to-end cardiac monitoring service can help you create a better experience for your patients and achieve your program goals. 

Patient wearing Zio monitor pouring a smoothie
Find support throughout your iRhythm cardiac monitoring experience with answers to commonly asked questions.

Precision is at the heart of iRhythm

iRhythm continually strives to perfect the cardiac monitoring experience. Our patient-friendly1 Zio ECG monitors and end-to-end service deliver trustworthy data, enabling accurate diagnoses8 from the start.3-7

Improved wear experience

Zio ECG monitors are designed to be comfortable2,9 and easy to wear1 for better patient satisfaction and compliance2,9

Patient wearing Zio monitor

Outstanding patient compliance

Near-perfect patient compliance2 generates high-quality, actionable data3

Remarkable clinical outcomes

Compared to other monitoring services, including long-term continuous monitors (LTCMs), the iRhythm LTCM service is a continuous, uninterrupted10 cardiac monitor associated with:

 

Highest diagnostic yield of specified arrhythmias4-7

Lowest likelihood of retesting4-7

More than a monitor

The iRhythm monitoring service is transforming cardiac monitoring end to end.

iRhythm technology on laptop and cell phone
Allows providers to interpret reports, manage patients, and more — from the computer or on the go with the provider mobile app.11
Simplifies data collection and entry, enhances interdisciplinary access, and boosts workflow efficiency.
Equips physicians with data analysis of the full wear time generated by FDA-cleared, advanced AI and verified by Certified Cardiographic Technicians (CCTs).12-15
Supports patients throughout their monitoring journey with digital symptom logging, educational content, and reminders.
User researching iRhythm on computer

Incredible 99% physician agreement with end-of-wear reports

The iRhythm monitoring service combines the only FDA-cleared, deep-learned algorithm verified by CCTs12-15 to generate reports with 99% physician agreement,16 which can lead to an accurate and timely diagnosis.3-8

~8 million patients analyzed1

Over 1.5 billion hours of curated heartbeat data1

Comprehensive reports verified by CCTs12-15

Keep reading

Clinical Article
Reynolds et al, American Heart Journal, 2023.
Comparative Effectiveness of ACM Strategies (CAMELOT Study)
A retrospective study of variations in ACM strategies, clinical outcomes and health care costs in diagnostic-naïve patients
Read more
Clinical Article
Turakhia et al., The American Journal of Cardiology, 2013.
Diagnostic Utility of a Novel Leadless Arrhythmia Monitor
A retrospective study of analyzable time, timing to arrhythmia detection and diagnostic yield of the Zio device
Read more
Clinical Article
Rosenberg et al., Pacing and Clinical Electrophysiology, 2013.
Noninvasive Continuous Monitor in Management of AF
A prospective head-to-head comparison of Zio device vs. 24-hour Holter monitors in patients with PAF
Read more
  1. Data on file. iRhythm Technologies, 2023.
  2. Data on file. iRhythm Technologies, 2022.
  3. Data on file. iRhythm Technologies, 2022-2023.
  4. Reynolds et al. Comparative effectiveness and healthcare utilization for ambulatory cardiac monitoring strategies in Medicare beneficiaries. Am Heart J. 2024;269:25-34. Accessed January 2, 2024. doi.org/10.1016/j.ahj.2023.12.002
  5. Based on previous generation Zio XT device data. Zio monitor utilizes the same operating principles and ECG algorithm. Additional data on file.
  6. A specified arrhythmia refers to an arrhythmia encounter diagnosis as per Hierarchical Condition Categories (HCC) 96.
  7. iRhythm LTCM service refers to Zio XT and Zio monitor service.
  8. Preliminary findings in the Zio report are intended for use by clinicians as an aid in arrhythmia diagnosis and management.
  9. Zio monitor Instructions for Use. iRhythm Technologies, 2023.
  10. Uninterrupted refers to ECG data recording.
  11. ZioSuite Clinical Reference Manual. iRhythm Technologies, 2022.
  12. Data on file. iRhythm Technologies, 2020.​
  13. Hannun et al. Cardiologist-level arrhythmia detection and classification in ambulatory electrocardiograms using a deep neural network. Nat Med. 2019;25:65-69. doi.org/10.1038/s41591-018-0268-3
  14. Deep-learned algorithm is only available in the United States, European Union, Switzerland, and United Kingdom.
  15. FDA 510K clearance, CE mark, and UKCA mark.
  16. 99% of physicians agree with the comprehensive end-of-wear report. Based on a review of all online Zio XT, Zio monitor, and Zio AT end-of-wear reports. Data on file. iRhythm Technologies, 2023.

WEB0001.01